Dr. Kimberly Gale Borden, MD

Dr. Borden practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Borden's NPI, 1063900165, was assigned on April 25, 2018. Dr. Borden graduated from David Geffen School of Medicine at UCLA in 2018. Dr. Borden's California license number on file is A164224.

Dr. Borden's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Borden's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Borden is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Riverside Faculty Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borden practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Borden's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Borden is board certified in internal medicine by the American Board of Internal Medicine. Dr. Borden has a license on file in California.

Dmand AI lists acute respiratory failure, gastrointestinal bleeding, kidney failure, lung disease: COPD, asthma or bronchitis, psychoses, sepsis, substance abuse and syncope & collapse among the conditions Dr. Borden treats.

CMS data shows 321 Medicare services from Dr. Borden across 5 procedure codes in 2024, for 126 Medicare patients. Medicare paid $26,981 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Borden in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 82% are also on Medicaid. Their average risk score is 3.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Borden's median patient age at 62, with 58% women.

In 2024, Dr. Borden wrote 185 Medicare Part D claims for 65 patients. 83% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $162 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Borden for performance year 2024, reported as part of a group. Dr. Borden accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Borden graduated from David Geffen School of Medicine at UCLA in 2018.

Dr. Borden is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.